Market revenue in 2022 | USD 36.0 million |
Market revenue in 2030 | USD 170.3 million |
Growth rate | 21.4% (CAGR from 2022 to 2030) |
Largest segment | Cell therapy |
Fastest growing segment | Gene Therapy |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Gene Therapy, Cell Therapy |
Key market players worldwide | Lonza Group Ltd, Bluebird bio Inc, Catalent Inc, Roche, Samsung BioLogics, Boehringer Ingelheim, Hitachi Ltd, Takara Bio Inc, Miltenyi Biotec, Thermo Fisher Scientific Inc, Novartis AG ADR, Merck KGaA, Wuxi AppTec Co Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell and gene therapy manufacturing market will help companies and investors design strategic landscapes.
Cell therapy was the largest segment with a revenue share of 67.22% in 2022. Horizon Databook has segmented the Argentina cell and gene therapy manufacturing market based on gene therapy, cell therapy covering the revenue growth of each sub-segment from 2018 to 2030.
Argentina is a developing market for stem cell therapies; hence, regional expansion of facilities is a key trend being witnessed in the country. Argentina has a substantial number of researchers in private and public institutions conducting research in stem cells & regenerative medicine.
In December 2021, Stem Cell Center opened a new facility in Córdoba, Argentina, with an aim to expand regenerative medicine in the country.
Thus, such initiatives are likely to boost market growth in the coming years. In addition, in August 2022, Catalent, a provider of advanced delivery technologies, cell & gene therapies, and biologics, announced the expansion of its site in Buenos Aires.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina cell and gene therapy manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Argentina cell and gene therapy manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account